Brigitte Smith
Director/Board Member chez PLATINUM INVESTMENT MANAGEMENT LIMITED
Fortune : 59 186 $ au 31/03/2024
Profil
Brigitte Helen Smith is the founder of GBS Venture Partners Pty Ltd.
(founded in 1996) and AirXpanders, Inc. (founded in 2010).
She is currently a Director at Neurovance, Inc., Platinum Asset Management Ltd., Neuromonics, Inc., Moximed, Inc., Elastagen Pty Ltd., Endoluminal Sciences Pty Ltd., Centre for Eye Research Australia, VisAbility Ltd., Neuromonics Pty Ltd., and Amber Electric Pty Ltd.
Ms. Smith has previously held positions as Chairman at Syntara Ltd.
and Viveve, Inc., Chairman at Viveve Medical, Inc. from 2014 to 2016, Independent Director at Humanigen, Inc. from 2004 to 2013, Director at Proacta, Inc., Smart Drug Systems, Inc., Xenome Ltd., Proacta Therapeutics Ltd., Applied Physiology Pty Ltd., Cortical Pty Ltd., Wolfson Dynamic Hearing Pty Ltd., Euthymics Bioscience, Inc., and Associate Consultant at Bain & Co., Inc. Ms. Smith has an undergraduate degree from the University of Melbourne, a graduate degree from Fletcher School of Law, and an MBA from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2023 | 84 000 ( 0,01% ) | 59 186 $ | 31/03/2024 |
Postes actifs de Brigitte Smith
| Sociétés | Poste | Début |
|---|---|---|
| PLATINUM INVESTMENT MANAGEMENT LIMITED | Director/Board Member | 31/03/2018 |
Moximed, Inc.
 Moximed, Inc. Medical SpecialtiesHealth Technology Moximed, Inc. develops minimally invasive, joint sparing solutions for patients with knee osteoarthritis. Its Osteoarthritis treatment can minimize joint pain, restore normal activity levels, and slow down disease progression. The company was founded by Anton G. Clifford in 2006 and is headquartered in Hayward, CA. | Director/Board Member | - |
VisAbility Ltd.
 VisAbility Ltd. Home FurnishingsConsumer Durables VisAbility Ltd. provides house holder services. The company is headquartered in Victoria Park, Australia. | Director/Board Member | - |
Elastagen Pty Ltd.
 Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia. | Director/Board Member | - |
| Centre for Eye Research Australia | Director/Board Member | - |
Neurovance, Inc.
 Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Endoluminal Sciences Pty Ltd.
 Endoluminal Sciences Pty Ltd. Medical DistributorsDistribution Services Endoluminal Sciences Pty Ltd. develops novel platform technologies for endovascular prostheses. The firm’s focus is to develop the treatment of abdominal aortic aneurysms (AAAs). The company was founded by Ashish Mitra and Martin Ng in 2007 and is headquartered in Sydney, Australia. | Director/Board Member | - |
| Neuromonics Pty Ltd. | Director/Board Member | - |
Neuromonics, Inc.
 Neuromonics, Inc. Medical SpecialtiesHealth Technology Neuromonics, Inc. manufactures and distributes medical devices for long-term relief of tinnitus. The firm offers Neuromonics tinnitus treatment which is used for the treatment of tinnitus. The company was founded by Paul B. Davis in 2001 and is headquartered in Westminster, CO. | Director/Board Member | - |
| ░░░ ░░░░░░░ ░░░░░░░░ ░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Brigitte Smith
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Formation de Brigitte Smith
| University of Melbourne | Undergraduate Degree |
| Fletcher School of Law | Graduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| HUMANIGEN, INC. | Health Technology |
| SYNTARA LIMITED | Health Technology |
| PLATINUM INVESTMENT MANAGEMENT LIMITED | Miscellaneous |
| VIVEVE MEDICAL, INC. | Health Technology |
| Entreprise privées | 21 |
|---|---|
Proacta, Inc.
 Proacta, Inc. BiotechnologyHealth Technology Proacta, Inc. develops drugs to treat cancer. It is developing a new generation of hypoxia-activated prodrug compounds to treat cancer. The firm’s lead product PR610, is a proprietary, hypoxia-activated prodrug with potential antineoplastic activity. The company was founded in 2001 by William A. Denny, Amato J. Giaccia, William Robert Wilson and Martin J. Brown and is headquartered in La Jolla, CA. | Health Technology |
Smart Drug Systems, Inc.
 Smart Drug Systems, Inc. Drugstore ChainsRetail Trade Smart Drug Systems, Inc. develops innovative drug delivery systems for animals. Its products are used for the animal health pharmaceutical market utilizing patented drug delivery systems. The company was founded in 1998 by Serge R. Martinod and Mal Brandon and is headquartered in Pawcatuck, CT | Retail Trade |
Viveve, Inc.
 Viveve, Inc. Medical SpecialtiesHealth Technology Viveve, Inc. engages in the development of medical devices that promote personal health and wellness. It offers InControl products and Viveve system solutions. The company was founded by Jonathan B. Parmer in 2005 and is headquartered in Englewood, CO. | Health Technology |
AirXpanders, Inc.
 AirXpanders, Inc. Medical SpecialtiesHealth Technology AirXpanders, Inc. engaged in the design, manufacture, sale and distribution of medical devices. It offers AeroForm Tissue Expander System, a needle-free, patient-controlled tissue expander used in patients undergoing two-stage breast reconstruction following mastectomy prior to the insertion of a breast implant. The company was founded by Daniel I. Jacobs, Barry Cheskin, and Teddy Shalon on March 17, 2005 and was headquartered in San Jose, CA. | Health Technology |
Neurovance, Inc.
Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Commercial Services |
Bain & Co., Inc.
 Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA. | Commercial Services |
Xenome Ltd.
 Xenome Ltd. Pharmaceuticals: MajorHealth Technology Xenome Ltd. discovered and developed peptide pharmaceuticals. Its product, Xen2174, was a novel conopeptide analogue for the treatment of severe pain. The company was founded in 2008 and was headquartered in Indooroopilly, Australia. | Health Technology |
GBS Venture Partners Pty Ltd.
 GBS Venture Partners Pty Ltd. Investment ManagersFinance GBS Venture Partners Pty Ltd (GBS Venture Partners) is a venture capital firm founded in 1996 by Helen Brigitte Smith and Geoff E.D Brooke. The firm is headquartered in Melbourne. | Finance |
Neuromonics, Inc.
Neuromonics, Inc. Medical SpecialtiesHealth Technology Neuromonics, Inc. manufactures and distributes medical devices for long-term relief of tinnitus. The firm offers Neuromonics tinnitus treatment which is used for the treatment of tinnitus. The company was founded by Paul B. Davis in 2001 and is headquartered in Westminster, CO. | Health Technology |
Applied Physiology Pty Ltd.
 Applied Physiology Pty Ltd. Medical DistributorsDistribution Services Applied Physiology developed and commercializes guidance devices for use in the critical care environment. Navigator™, the flagship product, focuses on hemodynamic management. Applied Physiology aims to develop products that make life easier for the clinician. The devices continuously acquire physiological data from conventional monitors and use it to create a graphical depiction of the patient position, and continuous advice on the next therapy. Applied Physiology's devices enable the implementation of targeted therapy to optimize care and outcomes. The clinician specifies target ranges for the variables being monitored. The devices graphically display the patient position in relation to these targets, and indicate a course of therapy that will guide the patient to the target area. This self-adaptive protocol facilitates a safe and systematic approach to bedside care, where whole teams work toward a unified goal. Applied Physiology's therapeutic guidance devices have demonstrated potential benefits for both clinicians and patients: Clinical teamwork is enhanced and goals unified, Improved patient put comes, Reduced length of stay and Reduced morbidity in critical care units. At the heart of Applied Physiology's technology are mathematical algorithms based on a combination of systems physiology and control engineering methods. This rigorous basis has enabled the development of sound and reliable patient-specific solutions to treatment planning problems that are often counter-intuitive. Applied Physiology's flagship product Navigator™, which targets pressure and flow in the circulatory system, will be available for sale in Europe and Australia in the second quarter 2010. It will be available for sale in the U.S. pending regulatory approval from the FDA. The company is based Australia, and established European operations in the UK in 2008. | Distribution Services |
Cortical Pty Ltd.
 Cortical Pty Ltd. BiotechnologyHealth Technology Cortical Pty Ltd. discovers and develops medical drugs for the treatment of inflammatory and proliferative diseases. The company was founded in 2003 by Eric F. Morand and Magdy N. Iskander and is headquartered in Clayton, Australia. | Health Technology |
Wolfson Dynamic Hearing Pty Ltd.
 Wolfson Dynamic Hearing Pty Ltd. Computer CommunicationsElectronic Technology Wolfson Dynamic Hearing Pty Ltd. provides digital signal processing software solutions. he company was founded by Elaine Saunders and Peter Blamey in 2003 and is headquartered in Richmond, Australia. | Electronic Technology |
Moximed, Inc.
Moximed, Inc. Medical SpecialtiesHealth Technology Moximed, Inc. develops minimally invasive, joint sparing solutions for patients with knee osteoarthritis. Its Osteoarthritis treatment can minimize joint pain, restore normal activity levels, and slow down disease progression. The company was founded by Anton G. Clifford in 2006 and is headquartered in Hayward, CA. | Health Technology |
Elastagen Pty Ltd.
Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia. | Health Technology |
Euthymics Bioscience, Inc.
 Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA. | Commercial Services |
Endoluminal Sciences Pty Ltd.
Endoluminal Sciences Pty Ltd. Medical DistributorsDistribution Services Endoluminal Sciences Pty Ltd. develops novel platform technologies for endovascular prostheses. The firm’s focus is to develop the treatment of abdominal aortic aneurysms (AAAs). The company was founded by Ashish Mitra and Martin Ng in 2007 and is headquartered in Sydney, Australia. | Distribution Services |
| Centre for Eye Research Australia | Government |
VisAbility Ltd.
VisAbility Ltd. Home FurnishingsConsumer Durables VisAbility Ltd. provides house holder services. The company is headquartered in Victoria Park, Australia. | Consumer Durables |
| Neuromonics Pty Ltd. | |
Amber Electric Pty Ltd.
 Amber Electric Pty Ltd. Internet Software/ServicesTechnology Services Amber Electric Pty Ltd. operates as a platform which uses real-time wholesale pricing to help customers use cheap renewables. The company was founded by Christopher Thompson and Dan Adams in December 2017 and is headquartered in Australia. | Technology Services |
Proacta Therapeutics Ltd.
 Proacta Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Proacta Therapeutics Ltd. develops cancer drugs which target physiological attributes of tumors. The company was founded in 2001 and is headquartered in Auckland, New Zealand. | Health Technology |
